Investor Presentaiton slide image

Investor Presentaiton

Appendix 1. Novo Nordisk at a glance 2. Insulin 3. GLP-1 diabetes Investor Presentation First six months of 2018. Slide 20 21 33 59 4. Obesity 79 5. Biopharmaceuticals & Other serious chronic diseases 88 6. Financials 100 7. Sustainable business 112 changing diabetes® novo nordisk
View entire presentation